{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T19:22:50Z","timestamp":1780341770173,"version":"3.54.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T00:00:00Z","timestamp":1554249600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gastric Cancer"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1007\/s10120-019-00957-5","type":"journal-article","created":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T04:42:14Z","timestamp":1554352934000},"page":"1274-1284","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Does neoadjuvant chemotherapy cancel out the negative survival impact induced by surgical complications after gastrectomy?"],"prefix":"10.1007","volume":"22","author":[{"given":"Masato","family":"Hayashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1936-9484","authenticated-orcid":false,"given":"Takaki","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Yura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sho","family":"Otsuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukinori","family":"Yamagata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Morita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Katai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshirou","family":"Nishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,3]]},"reference":[{"key":"957_CR1","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1200\/JCO.2005.05.2308","volume":"24","author":"F Kamangar","year":"2006","unstructured":"Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol. 2006;24:2137\u201350.","journal-title":"J Clin Oncol"},{"key":"957_CR2","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1002\/bjs.6665","volume":"96","author":"T Yoshikawa","year":"2009","unstructured":"Yoshikawa T, Sasako M, Yamamoto S, Sano T, Imamura H, Fujitani K, et al. Phase II study of neoadjuvant chemotherapy and extended surgery for locally advanced gastric cancer. Br J Surg. 2009;96:1015\u201322.","journal-title":"Br J Surg"},{"key":"957_CR3","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1002\/bjs.5513","volume":"93","author":"S Gretschel","year":"2006","unstructured":"Gretschel S, Siegel R, Est\u00e9vez-Schwarz L, H\u00fcnerbein M, Schneider U, Schlag PM, et al. Surgical strategies for gastric cancer with synchronous peritoneal carcinomatosis. Br J Surg. 2006;93:1530\u20135.","journal-title":"Br J Surg"},{"key":"957_CR4","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1097\/SLA.0000000000001828","volume":"265","author":"K Kataoka","year":"2017","unstructured":"Kataoka K, Takeuchi H, Mizusawa J, Igaki H, Ozawa S, Abe T, et al. Prognostic impact of postoperative morbidity after esophagectomy for esophageal cancer: exploratory analysis of JCOG9907. Ann Surg. 2017;265:1152\u20137.","journal-title":"Ann Surg"},{"key":"957_CR5","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1097\/01.sla.0000179621.33268.83","volume":"242","author":"SF Khuri","year":"2005","unstructured":"Khuri SF, Henderson WG, DePalma RG, Mosca C, Healey NA, Kumbhani DJ, et al. Determinants of long-term survival after major surgery and the adverse effect of postoperative complications. Ann Surg. 2005;242:326\u201341.","journal-title":"Ann Surg"},{"key":"957_CR6","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1097\/SLA.0b013e3182a6f2fc","volume":"259","author":"PM Krarup","year":"2014","unstructured":"Krarup PM, Nordholm-Carstensen A, Jorgensen LN, Harling H. Anastomotic leak increases distant recurrence and long-term mortality after curative resection for colonic cancer: a nationwide cohort study. Ann Surg. 2014;259:930\u20138.","journal-title":"Ann Surg"},{"key":"957_CR7","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1002\/bjs.7038","volume":"97","author":"M Sierzega","year":"2010","unstructured":"Sierzega M, Kolodziejczyk P, Kulig J. Impact of anastomotic leakage on long-term survival after total gastrectomy for carcinoma of the stomach. Br J Surg. 2010;97:1035\u201342.","journal-title":"Br J Surg"},{"key":"957_CR8","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1245\/s10434-012-2720-9","volume":"20","author":"M Tokunaga","year":"2013","unstructured":"Tokunaga M, Tanizawa Y, Bando E, Kawamura T, Terashima M. Poor survival rate in patients with postoperative intra-abdominal infectious complications following curative gastrectomy for gastric cancer. Ann Surg Oncol. 2013;20:1575\u201383.","journal-title":"Ann Surg Oncol"},{"key":"957_CR9","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1245\/s10434-013-3384-9","volume":"21","author":"T Kubota","year":"2014","unstructured":"Kubota T, Hiki N, Sano T, Nomura S, Nunobe S, Kumagai K, et al. Prognostic significance of complications after curative surgery for gastric cancer. Ann Surg Oncol. 2014;21:891\u20138.","journal-title":"Ann Surg Oncol"},{"key":"957_CR10","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.cyto.2008.07.014","volume":"43","author":"G Germano","year":"2008","unstructured":"Germano G, Allavena P, Mantovani A. Cytokines as a key component of cancer-related inflammation. Cytokine. 2008;43:374\u20139.","journal-title":"Cytokine"},{"key":"957_CR11","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nature01322","volume":"420","author":"LM Coussens","year":"2002","unstructured":"Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420:860\u20137.","journal-title":"Nature"},{"issue":"13","key":"957_CR12","doi-asserted-by":"publisher","first-page":"4453","DOI":"10.1245\/s10434-015-4557-5","volume":"22","author":"S Matsuda","year":"2015","unstructured":"Matsuda S, Takeuchi H, Kawakubo H, Fukuda K, Nakamura R, Takahashi T, et al. Correlation between intense postoperative inflammatory response and survival of esophageal cancer patients who underwent transthoracic esophagectomy. Ann Surg Oncol. 2015;22(13):4453\u201360. https:\/\/doi.org\/10.1245\/s10434-015-4557-5 Epub 2015 Apr 18.","journal-title":"Ann Surg Oncol"},{"key":"957_CR13","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa055531","volume":"355","author":"D Cunningham","year":"2006","unstructured":"Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, Nicolson M, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006;355:11\u201320.","journal-title":"N Engl J Med"},{"key":"957_CR14","doi-asserted-by":"publisher","first-page":"5210","DOI":"10.1200\/JCO.2009.26.6114","volume":"28","author":"C Schuhmacher","year":"2010","unstructured":"Schuhmacher C, Gretschel S, Lordick F, Reichardt P, Hohenberger W, Eisenberger CF, et al. Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: european organisation for research and treatment of cancer randomized trial 40954. J Clin Oncol. 2010;28:5210\u20138.","journal-title":"J Clin Oncol"},{"key":"957_CR15","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1007\/s00280-013-2130-0","volume":"71","author":"A Tsuburaya","year":"2013","unstructured":"Tsuburaya A, Nagata N, Cho H, Hirabayashi N, Kobayashi M, Kojima H, et al. Phase II trial of paclitaxel and cisplatin as neoadjuvant chemotherapy for locally advanced gastric cancer. Cancer Chemother Pharmacol. 2013;71:1309\u201314.","journal-title":"Cancer Chemother Pharmacol"},{"key":"957_CR16","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s00280-013-2350-3","volume":"73","author":"T Kosaka","year":"2014","unstructured":"Kosaka T, Akiyama H, Makino H, Takagawa R, Kimura J, Ono H, et al. Preoperative S-1 and docetaxel combination chemotherapy in patients with locally advanced gastric cancer. Cancer Chemother Pharmacol. 2014;73:281\u20135.","journal-title":"Cancer Chemother Pharmacol"},{"key":"957_CR17","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1245\/s10434-014-3594-9","volume":"21","author":"E Oki","year":"2014","unstructured":"Oki E, Emi Y, Kusumoto T, Sakaguchi Y, Yamamoto M, Sadanaga N, et al. Phase II study of docetaxel and S-1 (DS) as neoadjuvant chemotherapy for clinical stage III resectable gastric cancer. Ann Surg Oncol. 2014;21:2340\u20136.","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"957_CR18","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s10120-017-0781-y","volume":"21","author":"K Eto","year":"2018","unstructured":"Eto K, Hiki N, Kumagai K, Shoji Y, Tsuda Y, Kano Y, et al. Prophylactic effect of neoadjuvant chemotherapy in gastric cancer patients with postoperative complications. Gastric Cancer. 2018;21(4):703\u20139. https:\/\/doi.org\/10.1007\/s10120-017-0781-y Epub 2017 Nov 29.","journal-title":"Gastric Cancer"},{"issue":"(15_suppl)","key":"957_CR19","doi-asserted-by":"publisher","first-page":"4046","DOI":"10.1200\/JCO.2018.36.15_suppl.4046","volume":"15","author":"Y Iwasaki","year":"2018","unstructured":"Iwasaki Y, Terashima M, Mizusawa J, Katayama H, Nakamura K, Katai H, et al. Randomized phase III trial of gastrectomy with or without neoadjuvant S-1 plus cisplatin for type 4 or large type 3 gastric cancer: Japan clinical oncology group study (JCOG0501). J Clin Oncol. 2018;15(15_suppl):4046\u20134046. https:\/\/doi.org\/10.1200\/JCO.2018.36.15_suppl.4046","journal-title":"J Clin Oncol."},{"key":"957_CR20","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s10120-011-0041-5","volume":"14","author":"Japanese Gastric Cancer Association","year":"2011","unstructured":"Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma: 3rd english edition. Gastric Cancer. 2011;14:101\u201312. https:\/\/doi.org\/10.1007\/s10120-011-0041-5 .","journal-title":"Gastric Cancer"},{"key":"957_CR21","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205\u201313.","journal-title":"Ann Surg"},{"issue":"6","key":"957_CR22","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1007\/s00595-015-1236-x","volume":"46","author":"H Katayama","year":"2016","unstructured":"Katayama H, Kurokawa Y, Nakamura K, Ito H, Kanemitsu Y, Masuda N, et al. Extended Clavien-Dindo classification of surgical complications: Japan clinical oncology group postoperative complications criteria. Surg Today. 2016;46(6):668\u201385. https:\/\/doi.org\/10.1007\/s00595-015-1236-x Epub 2015 Aug 20.","journal-title":"Surg Today"},{"issue":"3","key":"957_CR23","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1097\/00000658-199903000-00001","volume":"229","author":"AM Lowy","year":"1999","unstructured":"Lowy AM, Mansfield PF, Leach SD, Pazdur R, Dumas P, Ajani JA. Response to neoadjuvant chemotherapy best predicts survival after curative resection of gastric cancer. Ann Surg. 1999;229(3):303\u20138.","journal-title":"Ann Surg"},{"issue":"3","key":"957_CR24","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s10120-014-0401-z","volume":"18","author":"K Nakamura","year":"2015","unstructured":"Nakamura K, Kuwata T, Shimoda T, Mizusawa J, Katayama H, Kushima R, et al. Determination of the optimal cutoff percentage of residual tumors to define the pathological response rate for gastric cancer treated with preoperative therapy (JCOG1004-A). Gastric Cancer. 2015;18(3):597\u2013604. https:\/\/doi.org\/10.1007\/s10120-014-0401-z Epub 2014 Jun 27.","journal-title":"Gastric Cancer"},{"issue":"6","key":"957_CR25","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1002\/bjs.9484","volume":"101","author":"A Tsuburaya","year":"2014","unstructured":"Tsuburaya A, Mizusawa J, Tanaka Y, Fukushima N, Nashimoto A, Sasako M, et al. Neoadjuvant chemotherapy with S-1 and cisplatin followed by D2 gastrectomy with para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis. Br J Surg. 2014;101(6):653\u201360. https:\/\/doi.org\/10.1002\/bjs.9484 Epub 2014 Mar 25.","journal-title":"Br J Surg"},{"key":"957_CR26","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.3389\/fimmu.2017.01194","volume":"8","author":"A Zingoni","year":"2017","unstructured":"Zingoni A, Fionda C, Borrelli C, Cippitelli M, Santoni A, Soriani A. Natural killer cell response to chemotherapy-stressed cancer cells: role in tumor immunosurveillance. Front Immunol. 2017;8:1194. https:\/\/doi.org\/10.3389\/fimmu.2017.01194 eCollection2017.","journal-title":"Front Immunol"}],"container-title":["Gastric Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10120-019-00957-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10120-019-00957-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10120-019-00957-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T05:42:47Z","timestamp":1663220567000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10120-019-00957-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,3]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["957"],"URL":"https:\/\/doi.org\/10.1007\/s10120-019-00957-5","relation":{},"ISSN":["1436-3291","1436-3305"],"issn-type":[{"value":"1436-3291","type":"print"},{"value":"1436-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,3]]},"assertion":[{"value":"8 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have no conflicts of interest that are directly relevant to the content of this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}